Abstract
BackgroundCytotoxic or anti-TNF therapies increase risk of reactivation of latent tuberculosis infection (LTBI). Therefore screening for latent tuberculosis is mandatory before initiating therapy. On the other hand, these patients who...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
